<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34062974</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2379-139X</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>May</Month><Day>05</Day></PubDate></JournalIssue><Title>Tomography (Ann Arbor, Mich.)</Title><ISOAbbreviation>Tomography</ISOAbbreviation></Journal><ArticleTitle>Evaluation of Amyotrophic Lateral Sclerosis-Induced Muscle Degeneration Using Magnetic Resonance-Based Relaxivity Contrast Imaging (RCI).</ArticleTitle><Pagination><StartPage>169</StartPage><EndPage>179</EndPage><MedlinePgn>169-179</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/tomography7020015</ELocationID><Abstract><AbstractText>(1) Background: This work characterizes the sensitivity of magnetic resonance-based Relaxivity Contrast Imaging (RCI) to Amyotrophic Lateral Sclerosis (ALS)-induced changes in myofiber microstructure. Transverse Relaxivity at Tracer Equilibrium (TRATE), an RCI-based parameter, was evaluated in the lower extremities of ALS patients and healthy subjects. (2) Methods: In this IRB-approved study, 23 subjects (12 ALS patients and 11 healthy controls) were scanned at 3T (Philips, The Netherlands). RCI data were obtained during injection of a gadolinium-based contrast agent. TRATE, fat fraction and T<sub>2</sub> measures, were compared in five muscle groups of the calf muscle, between ALS and control populations. TRATE was also evaluated longitudinally (baseline and 6 months) and was compared to clinical measures, namely ALS Functional Rating Scale (ALSFRS-R) and Hand-Held Dynamometry (HHD), in a subset of the ALS population. (3) Results: TRATE was significantly lower (<i>p</i> &lt; 0.001) in ALS-affected muscle than in healthy muscle in all muscle groups. Fat fraction differences between ALS and healthy muscle were statistically significant for the tibialis anterior (<i>p</i> = 0.01), tibialis posterior (<i>p</i> = 0.004), and peroneus longus (<i>p</i> = 0.02) muscle groups but were not statistically significant for the medial (<i>p</i> = 0.07) and lateral gastrocnemius (<i>p</i> = 0.06) muscles. T<sub>2</sub> differences between ALS and healthy muscle were statistically significant for the tibialis anterior (<i>p</i> = 0.004), peroneus longus (<i>p</i> = 0.004) and lateral gastrocnemius (<i>p</i> = 0.03) muscle groups but were not statistically significant for the tibialis posterior (<i>p</i> = 0.06) and medial gastrocnemius (<i>p</i> = 0.07) muscles. Longitudinally, TRATE, averaged over all patients, decreased by 28 &#xb1; 16% in the tibialis anterior, 47 &#xb1; 18% in the peroneus longus, 25 &#xb1; 19% in the tibialis posterior, 29 &#xb1; 14% in the medial gastrocnemius and 35 &#xb1; 18% in the lateral gastrocnemius muscles between two timepoints. ALSFRS-R scores were stable in two of four ALS patients. HHD scores decreased in three of four ALS patients. (4) Conclusion: RCI-based TRATE was shown to consistently differentiate ALS-affected muscle from healthy muscle and also provide a quantitative measure of longitudinal muscle degeneration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ragunathan</LastName><ForeName>Sudarshan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2871-1758</Identifier><AffiliationInfo><Affiliation>Barrow Neuroimaging Innovation Center, Division of Neuroimaging Research, Barrow Neurological Institute, Phoenix, AZ 85013, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>Laura C</ForeName><Initials>LC</Initials><Identifier Source="ORCID">0000-0001-8164-8324</Identifier><AffiliationInfo><Affiliation>Barrow Neuroimaging Innovation Center, Division of Neuroimaging Research, Barrow Neurological Institute, Phoenix, AZ 85013, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semmineh</LastName><ForeName>Natenael</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Barrow Neuroimaging Innovation Center, Division of Neuroimaging Research, Barrow Neurological Institute, Phoenix, AZ 85013, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stokes</LastName><ForeName>Ashley M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0003-1137-5003</Identifier><AffiliationInfo><Affiliation>Barrow Neuroimaging Innovation Center, Division of Neuroimaging Research, Barrow Neurological Institute, Phoenix, AZ 85013, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shefner</LastName><ForeName>Jeremy M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Barrow Neurological Institute, Phoenix, AZ 85013, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowser</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5404-7259</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Barrow Neurological Institute, Phoenix, AZ 85013, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurobiology, Barrow Neurological Institute, Phoenix, AZ 85013, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladha</LastName><ForeName>Shafeeq</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Gregory W. Fulton ALS and Neuromuscular Disease Center, Barrow Neurological Institute, Phoenix, AZ 85013, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quarles</LastName><ForeName>C Chad</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Barrow Neuroimaging Innovation Center, Division of Neuroimaging Research, Barrow Neurological Institute, Phoenix, AZ 85013, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2094</GrantID><Agency>Flinn Foundation</Agency><Country/></Grant><Grant><GrantID>3032285</GrantID><Agency>Fulton Family Foundation</Agency><Country/></Grant><Grant><GrantID>8032198</GrantID><Agency>Amyotrophic Lateral Sclerosis Association</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Tomography</MedlineTA><NlmUniqueID>101671170</NlmUniqueID><ISSNLinking>2379-1381</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">TRATE</Keyword><Keyword MajorTopicYN="N">muscle myofiber</Keyword><Keyword MajorTopicYN="N">perfusion MRI</Keyword><Keyword MajorTopicYN="N">relaxivity contrast imaging</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>2</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34062974</ArticleId><ArticleId IdType="pmc">PMC8162571</ArticleId><ArticleId IdType="doi">10.3390/tomography7020015</ArticleId><ArticleId IdType="pii">tomography7020015</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Paganoni S., Macklin E.A., Lee A., Murphy A., Chang J., Zipf A., Cudkowicz M., Atassi N. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS) Amyotroph. Lateral Scler. Front. Degener. 2014;15:453&#x2013;456. doi: 10.3109/21678421.2014.903974.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.903974</ArticleId><ArticleId IdType="pmc">PMC4433003</ArticleId><ArticleId IdType="pubmed">24981792</ArticleId></ArticleIdList></Reference><Reference><Citation>Voustianiouk A., Seidel G., Panchal J., Sivak M., Czaplinski A., Yen A., Appel S.H., Lange D.J. ALSFRS and appel ALS scores: Discordance with disease progression. Muscle Nerve. 2008;37:668&#x2013;672. doi: 10.1002/mus.20977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20977</ArticleId><ArticleId IdType="pubmed">18288708</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappello V., Francolini M. Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2017;18:2092. doi: 10.3390/ijms18102092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18102092</ArticleId><ArticleId IdType="pmc">PMC5666774</ArticleId><ArticleId IdType="pubmed">28972545</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams J.R., Fitzhenry D., Grant L., Martyn D., Kerr D.A. Diagnosis pathway for patients with amyotrophic lateral sclerosis: Retrospective analysis of the US Medicare longitudinal claims database. BMC Neurol. 2013;13:160. doi: 10.1186/1471-2377-13-160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-13-160</ArticleId><ArticleId IdType="pmc">PMC4029731</ArticleId><ArticleId IdType="pubmed">24499173</ArticleId></ArticleIdList></Reference><Reference><Citation>Walhout R., Verstraete E., Heuvel M.P.V.D., Veldink J.H., Berg L.H.V.D. Patterns of symptom development in patients with motor neuron disease. Amyotroph. Lateral Scler. Front. Degener. 2017;19:21&#x2013;28. doi: 10.1080/21678421.2017.1386688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1386688</ArticleId><ArticleId IdType="pubmed">29037065</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Chi&#xf2; A., Cosottini M., De Stefano N., Falini A., Mascalchi M., Rocca M., Silani V., Tedeschi G., Filippi M. The Present and the Future of Neuroimaging in Amyotrophic Lateral Sclerosis. Am. J. Neuroradiol. 2010;31:1769&#x2013;1777. doi: 10.3174/ajnr.A2043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A2043</ArticleId><ArticleId IdType="pmc">PMC7964007</ArticleId><ArticleId IdType="pubmed">20360339</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Pagani E., Petrolini M., Caputo D., Perini M., Prelle A., Salvi F., Filippi M. Assessment of White Matter Tract Damage in Patients with Amyotrophic Lateral Sclerosis: A Diffusion Tensor MR Imaging Tractography Study. Am. J. Neuroradiol. 2010;31:1457&#x2013;1461. doi: 10.3174/ajnr.A2105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A2105</ArticleId><ArticleId IdType="pmc">PMC7966122</ArticleId><ArticleId IdType="pubmed">20395382</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Bokde A.L., Byrne S., Elamin M., McLaughlin R.L., Kenna K., Fagan A.J., Pender N., Bradley D.G., Hardiman O. (2013 Neurology Bede) Multiparametric MRI study of ALS stratified for the C9orf72 genotype. Neurology. 2013;81:361&#x2013;369. doi: 10.1212/WNL.0b013e31829c5eee.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31829c5eee</ArticleId><ArticleId IdType="pmc">PMC3772833</ArticleId><ArticleId IdType="pubmed">23771489</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M., Dengler R., Eisen A., England J.D., Kaji R., Kimura J., Mills K., Mitsumoto H., Nodera H., Shefner J., et al. Electrodiagnostic criteria for diagnosis of ALS. Clin. Neurophysiol. 2008;119:497&#x2013;503. doi: 10.1016/j.clinph.2007.09.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.143</ArticleId><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkove S.B., Caress J.B., Cartwright M.S., Burns T.M., Warder J., David W.S., Goyal N., Maragakis N.J., Clawson L., Benatar M., et al. Electrical impedance myography as a biomarker to assess ALS progression. Amyotroph. Lateral Scler. 2012;13:439&#x2013;445. doi: 10.3109/17482968.2012.688837.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.688837</ArticleId><ArticleId IdType="pmc">PMC3422377</ArticleId><ArticleId IdType="pubmed">22670883</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkove S.B., Caress J.B., Cartwright M.S., Burns T.M., Warder J., David W.S., Goyal N., Maragakis N.J., Benatar M., Sharma K.R., et al. Electrical impedance myography correlates with standard measures of Als severity. Muscle Nerve. 2013;49:441&#x2013;443. doi: 10.1002/mus.24128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24128</ArticleId><ArticleId IdType="pubmed">24273034</ArticleId></ArticleIdList></Reference><Reference><Citation>Arts I.M., Overeem S., Pillen S., Kleine B.U., Boekestein W.A., Zwarts M.J., Schelhaas H.J. Muscle ultrasonography: A diagnostic tool for amyotrophic lateral sclerosis. Clin. Neurophysiol. 2012;123:1662&#x2013;1667. doi: 10.1016/j.clinph.2011.11.262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2011.11.262</ArticleId><ArticleId IdType="pubmed">22244867</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler E.A., Sengillo J.D., Sullivan J.S., Henkel J.S., Appel S.H., Zlokovic B.V. Blood&#x2013;spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol. 2012;125:111&#x2013;120. doi: 10.1007/s00401-012-1039-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1039-8</ArticleId><ArticleId IdType="pmc">PMC3535352</ArticleId><ArticleId IdType="pubmed">22941226</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins T.M., Alix J.J.P., David C., Pearson E., Rao D.G., Hoggard N., O&#x2019;Brien E., Baster K., Bradburn M., Bigley J., et al. Imaging muscle as a potential biomarker of denervation in motor neuron disease. J. Neurol. Neurosurg. Psychiatry. 2017;89:248&#x2013;255. doi: 10.1136/jnnp-2017-316744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316744</ArticleId><ArticleId IdType="pmc">PMC5869448</ArticleId><ArticleId IdType="pubmed">29089397</ArticleId></ArticleIdList></Reference><Reference><Citation>Klickovic U., Zampedri L., Sinclair C.D., Wastling S.J., Trimmel K., Howard R.S., Malaspina A., Sharma N., Sidle K., Emira A., et al. Skeletal muscle MRI differentiates SBMA and ALS and correlates with disease severity. Neurology. 2019;93:e895&#x2013;e907. doi: 10.1212/WNL.0000000000008009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008009</ArticleId><ArticleId IdType="pmc">PMC6745729</ArticleId><ArticleId IdType="pubmed">31391248</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Manera J., Llauger J., Gallardo E., Illa I. Muscle MRI in muscular dystrophies. Acta Myol. 2015;34:95&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4859076</ArticleId><ArticleId IdType="pubmed">27199536</ArticleId></ArticleIdList></Reference><Reference><Citation>Sourbron S., Heilmann M., Walczak C., Vautier J., Schad L.R., Volk A. T2*-relaxivity contrast imaging: First results. Magn. Reson. Med. 2012;69:1430&#x2013;1437. doi: 10.1002/mrm.24383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.24383</ArticleId><ArticleId IdType="pubmed">22733703</ArticleId></ArticleIdList></Reference><Reference><Citation>Semmineh N.B., Xu J., Skinner J.T., Xie J., Li H., Ayers G., Quarles C.C. Assessing tumor cytoarchitecture using multiecho DSC-MRI derived measures of the transverse relaxivity at tracer equilibrium (TRATE) Magn. Reson. Med. 2015;74:772&#x2013;784. doi: 10.1002/mrm.25435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.25435</ArticleId><ArticleId IdType="pmc">PMC4362846</ArticleId><ArticleId IdType="pubmed">25227668</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner J.M., Liu D., Leitner M.L., Schoenfeld D., Johns D.R., Ferguson T., Cudkowicz M. Quantitative strength testing in ALS clinical trials. Neurology. 2016;87:617&#x2013;624. doi: 10.1212/WNL.0000000000002941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002941</ArticleId><ArticleId IdType="pmc">PMC4977369</ArticleId><ArticleId IdType="pubmed">27385750</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson M., Bannister P., Brady M., Smith S. Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images. NeuroImage. 2002;17:825&#x2013;841. doi: 10.1006/nimg.2002.1132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nimg.2002.1132</ArticleId><ArticleId IdType="pubmed">12377157</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokes A.M., Quarles C.C. A simplified spin and gradient echo approach for brain tumor perfusion imaging. Magn. Reson. Med. 2016;75:356&#x2013;362. doi: 10.1002/mrm.25591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.25591</ArticleId><ArticleId IdType="pmc">PMC4561038</ArticleId><ArticleId IdType="pubmed">25753958</ArticleId></ArticleIdList></Reference><Reference><Citation>Fram E.K., Herfkens R.J., Johnson G., Glover G.H., Karis J.P., Shimakawa A., Perkins T.G., Pelc N.J. Rapid calculation of T1 using variable flip angle gradient refocused imaging. Magn. Reson. Imaging. 1987;5:201&#x2013;208. doi: 10.1016/0730-725X(87)90021-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0730-725X(87)90021-X</ArticleId><ArticleId IdType="pubmed">3626789</ArticleId></ArticleIdList></Reference><Reference><Citation>Quarles C.C., Gore J.C., Xu L., Yankeelov T.E. Comparison of dual-echo DSC-MRI- and DCE-MRI-derived contrast agent kinetic parameters. Magn. Reson. Imaging. 2012;30:944&#x2013;953. doi: 10.1016/j.mri.2012.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mri.2012.03.008</ArticleId><ArticleId IdType="pmc">PMC3569857</ArticleId><ArticleId IdType="pubmed">22617148</ArticleId></ArticleIdList></Reference><Reference><Citation>Min Y.G., Choi S.-J., Hong Y.-H., Kim S.-M., Shin J.-Y., Sung J.-J. Dissociated leg muscle atrophy in amyotrophic lateral sclerosis/motor neuron disease: The &#x2018;split-leg&#x2019; sign. Sci. Rep. 2020;10:15661. doi: 10.1038/s41598-020-72887-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-72887-7</ArticleId><ArticleId IdType="pmc">PMC7518279</ArticleId><ArticleId IdType="pubmed">32973334</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Z., Zhang H., Chen Z., van der Plas E., Gutmann L., Thedens D., Nopoulos P., Sonka M. Fully automated 3D segmentation of MR-imaged calf muscle compartments: Neighborhood relationship enhanced fully convolutional network. Comput. Med. Imaging Graph. 2021;87:101835. doi: 10.1016/j.compmedimag.2020.101835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compmedimag.2020.101835</ArticleId><ArticleId IdType="pmc">PMC7855601</ArticleId><ArticleId IdType="pubmed">33373972</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Troter A., Four&#xe9; A., Guye M., Confort-Gouny S., Mattei J.-P., Gondin J., Salort-Campana E., Bendahan D. Volume measurements of individual muscles in human quadriceps femoris using atlas-based segmentation approaches. Magn. Reson. Mater. Phys. Biol. Med. 2016;29:245&#x2013;257. doi: 10.1007/s10334-016-0535-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10334-016-0535-6</ArticleId><ArticleId IdType="pubmed">26983429</ArticleId></ArticleIdList></Reference><Reference><Citation>Essafi S., Langs G., Deux J.-F., Rahmouni A., Bassez G., Paragios N. Wavelet-driven knowledge-based MRI calf muscle segmentation; Proceedings of the 2009 IEEE International Symposium on Biomedical Imaging: From Nano to Macro; Boston, MA, USA. 28 June&#x2013;1 July 2009; pp. 225&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/isbi.2009.5193024</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues R., Pinheiro A.M. Segmentation of Skeletal Muscle in Thigh Dixon MRI Based on Texture Analysis. arXiv. 20191904.04747</Citation></Reference><Reference><Citation>Shefner J.M., Rutkove S.B., Caress J.B., Benatar M., David W.S., Cartwright M.S., Macklin E.A., Bohorquez J.L. Reducing sample size requirements for future ALS clinical trials with a dedicated electrical impedance myography system. Amyotroph. Lateral Scler. Front. Degener. 2018;19:555&#x2013;561. doi: 10.1080/21678421.2018.1510008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1510008</ArticleId><ArticleId IdType="pmc">PMC6438779</ArticleId><ArticleId IdType="pubmed">30265154</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez B., Rutkove S.B. Electrical Impedance Myography and Its Applications in Neuromuscular Disorders. Neurotherapeutics. 2017;14:107&#x2013;118. doi: 10.1007/s13311-016-0491-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-016-0491-x</ArticleId><ArticleId IdType="pmc">PMC5233633</ArticleId><ArticleId IdType="pubmed">27812921</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkove S.B. Electrical impedance myography: Background, current state, and future directions. Muscle Nerve. 2009;40:936&#x2013;946. doi: 10.1002/mus.21362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21362</ArticleId><ArticleId IdType="pmc">PMC2824130</ArticleId><ArticleId IdType="pubmed">19768754</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>